Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial
聚乙二醇干扰素α和利巴韦林延长治疗并不能改善基因型2/3且无快速病毒学应答患者的持续病毒学应答(OPTEX试验):一项前瞻性、随机、双臂、多中心IV期临床试验
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0128069
Heidrich, Benjamin; Cordes, Hans-Jörg; Klinker, Hartwig; Möller, Bernd; Naumann, Uwe; Rössle, Martin; Kraus, Michael R; Böker, Klaus H; Roggel, Christoph; Schuchmann, Marcus; Stoehr, Albrecht; Trein, Andreas; Hardtke, Svenja; Gonnermann, Andrea; Koch, Armin; Wedemeyer, Heiner; Manns, Michael P; Cornberg, Markus